Serum vitamin B 12 and folate, and their functional markers, plasma homocysteine and urinary methylmalonate (uMMA) were measured in 204 healthy, term infants at birth, and at 2 and 6 months. Compared with infants receiving formula food, those fed mother's milk had lower vitamin B 12 and folate at 2 and 6 months. In infants receiving mother's milk, vitamin B 12 levels were similar at birth (238 pg/ml) and 2 months (243 pg/ml), whereas with formula milk the level was significantly higher at 2 months (558 pg/ml) than at birth (257 pg/ml). Vitamin B 12 was negatively correlated with homocysteine at birth and 6 months. The level of uMMA (mmol/mol creatinine) was higher at 2 (mother's milk, 25.5; formula, 23.97) and 6 months (19.77; 15) than at birth (11.97; 10.88), and was not correlated with vitamin B 12 levels. Homocysteine may be a reliable marker of vitamin B 12 status in neonates and infants; however, uMMA is not suitable as a marker of vitamin B 12 status.
Introduction
Vitamin B 12 deficiency presents a clinical picture with no distinguishing findings, especially in children, and is difficult to detect. It may lead to nutritional deficiency, haematological changes, developmental problems and progressive neurological impairment. 1 Vitamin B 12 deficiency is a widespread public health problem, particularly in developing countries. 2 Owing to its negative, long-term effects on psychomotor development, early diagnosis is of particular importance. 1 -3 During the neonatal period and early childhood, levels of vitamin B 12 and its metabolites differ from those found in adulthood. 4, 5 Vitamin B 12 status may be determined by measuring serum vitamin B 12 , folate, homocysteine and methylmalonic acid (MMA). 6 -8 In infants, vitamin B 12 and folate values exhibit changes over time together with changes in their metabolic markers homocysteine and MMA. 1, 9 It has been reported in studies on adults that, because the concentration of urinary of MMA (uMMA) is 25 times greater than its serum concentration, the determination of uMMA may be a practical and reliable method of determining vitamin B 12 deficiency. 10, 11 There are insufficient F Karademir, S Suleymanoglu, A Ersen, et al.
Measuring vitamin B 12 status in infants studies on this subject in neonates and infants. Our aim was to investigate whether uMMA, reported as being practical and reliable when normalized for creatinine, could be used in the evaluation of vitamin B 12 status in neonates.
Subjects and methods

SUBJECTS
The study was conducted with appropriatefor-gestational-age term neonates born in our hospital (Gata Haydarpasa Teaching Hospital Uskudar, Istanbul, Turkey), with no congenital abnormality or metabolic disease, whose mothers were not vegetarians and had received supplementary folic acid during pregnancy. Growth and development of the infants were within the normal range at the 2-and 6-month follow-up in the present study. The neonates were divided into two groups according to feeding type (mother's milk and formula).
SAMPLES MEASURED
Vitamin B 12 , folic acid, plasma homocysteine and uMMA levels of all the infants were determined. Urine and blood samples were taken from all infants in compliance with the Gulhane Military Medical Academy Ethical Committee's requirements and with the family's informed written consent.
Umbilical cord blood and urine samples were taken from the infant within the first 2 days of life and again after 2 and 6 months. Serum folic acid and vitamin B 12 measurements were performed with an Access ® system (Beckman-Coulter, Fullerton, CA, USA) using a microparticulate immunoassay method. Plasma total homocysteine was measured using highperformance liquid chromatography and a fluorescence detection method; uMMA measurements were determined manually using a modified photometric method and the results were normalized for urinary creatinine concentration.
ANALYSIS OF DATA
SPSS ® for Windows ® (SPSS Inc., Chicago, IL, USA) was used to analyse the results. A descriptive statistical method (Tukey's weighted average, standard deviation) was used in the data analysis. Data were normally distributed and the differences were tested by using the Kolmogorov-Smirnov test. Kruskal-Wallis analysis of variance and the Mann-Whitney U-test were used to compare quantitative data between the groups. The Friedman test was used in the comparison of intragroup differences in vitamin B 12 , folate, total homocysteine and uMMA at months 2 and 6. The Pearson correlation test was used to examine correlations between parameters.
Results
There were 204 term neonates enrolled in the study. The mean (range) serum vitamin B 12 level at birth was 236 pg/ml (95 -1500 pg/ml), serum folate 14.3 ng/ml (4.2 -20 ng/ml), plasma homocysteine 7.5 µmol/l (2.7 -36.5 µmol/l) and uMMA 11.93 mmol/mol creatinine (1.2 -35.8 mmol/mol creatinine).
A negative correlation was found between vitamin B 12 and homocysteine at birth (r = -0.247, P < 0.001) and there was a positive correlation between vitamin B 12 and folate concentrations (r = 0.29, P < 0.001). There was a negative correlation between folate and homocysteine (r = -0.25, P < 0.001). No significant correlation between uMMA and any other variable was found.
Vitamin B 12 and folate levels were significantly lower in subjects receiving mother's milk at month 2 compared with those receiving formula (P < 0.01), whereas the homocysteine concentration was significantly higher in infants receiving F Karademir, S Suleymanoglu, A Ersen, et al. Measuring vitamin B 12 status in infants mother's milk than in those receiving formula (P = 0.01). There was no significant difference between the groups in uMMA levels at any time (Table 1 ). In 2-month old infants there was a significant negative correlation between vitamin B 12 and homocysteine levels in both groups (r = -0.523, P < 0.001). In addition, a significant positive correlation was found at this time between plasma homocysteine and uMMA levels (r = 0.339, P = 002) and between vitamin B 12 and folate levels in infants receiving formula food (r = 0.435, P = 0.027).
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Discussion
Vitamin B 12 status can be determined by measuring vitamin B 12 and folate in serum and homocysteine and MMA in plasma. Measurement of uMMA is a method with high sensitivity and specificity that can be used in adults for this purpose. 10, 11 Since there were negative correlations between serum B 12 and folate (r = -0.247) and between vitamin B 12 and plasma homocysteine (r = -0.25) at birth in our study, we considered that homocysteine might be used to reveal vitamin B 12 levels.
We found that formula consumption was accompanied by low homocysteine levels in the second month. The plasma homocysteine level is thought to be affected when infants receive greater amounts of vitamin B 12 and folate with formula than with mother's milk. The correlation with vitamin B 12 in the second month in infants receiving mother's milk in the present study shows that plasma homocysteine can be used as a vitamin B 12 marker in this month.
Plasma homocysteine exhibits a strong correlation with serum vitamin B 12 in infants younger than 6 months, and may be regarded as a basic marker of vitamin B 12 in infants in this age group. 8, 9, 12 The use of serum, plasma and uMMA measurements has made it possible to detect vitamin B 12 deficiency in adults and for folate deficiency to be used in the differential diagnosis. Since uMMA measurements are normalized for creatinine concentration and this is a non-invasive method, this may offer a new method of analysis for vitamin B 12 . 10, 11 In our study, we observed that uMMA levels in infants had a wider range than the normal range reported in children (2.0 -5.1 mmol/mol creatinine) and adults (0.7 -3.2 mmol/mol creatinine). 13 In addition, in contrast to studies reporting a higher uMMA concentration in infants receiving mother's milk compared with those on formula, our data revealed that uMMA was unrelated to the mode of nutrition. 13 The fact that, compared with at birth, the mean uMMA levels were higher, particularly in the second month, and that they exhibited no correlation with vitamin B 12 suggests that MMA metabolism may be different in this period from that in children and adults. High uMMA levels may be linked to the immaturity of enzyme systems in tissues related to MMA formation or metabolism, or to a condition linked to increased catabolism. 9 
